Evidence map›Paper›PMID 41385317›Full record

ArticleNucleic acids research2025

Commentary on 'Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments'.

Larry Melidis, Rafael de Cesaris Araujo Tavares, Xuan He, Somdutta Dhir, David Tannahill, Shankar Balasubramanian

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Larry MelidisYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 0RE, United Kingdom.
Rafael de Cesaris Araujo TavaresCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 1EW, United Kingdom.
Xuan HeYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 0RE, United Kingdom.
Somdutta DhirCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 1EW, United Kingdom.
David TannahillCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 1EW, United Kingdom.ORCID 0000-0002-3811-6864
Shankar BalasubramanianYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 0RE, United Kingdom.ORCID 0000-0002-0281-5815

Funding

CRUK C9681/A29214CRUK SEBINT-2024/100003University of Cambridge 209441/Z/17/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41385317
PMCPMC12700092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.